专利检索 ap:("Jo Klaveness" OR "Etnar Mustaparta" OR "Bjarne Brudeli" OR "Olaw Smidsrod" OR "Kjell Varum") AND inv:"Olaw Smidsrod" 第 1 页

1.

发明申请
Pharmaceutical compositions comprising an active agent and chitosan for sustained drug release or mucoadhesion 审中-公开
标题翻译：药物组合物包含活性剂和壳聚糖用于持续的药物释放或粘膜粘附

公开(公告)号：US20060293216A1

公开(公告)日：2006-12-28

申请号：US10544313

申请日：2004-02-06

申请人： Jo Klaveness , Etnar Mustaparta , Bjarne Brudeli , Olaw Smidsrod , Kjell Varum

发明人： Jo Klaveness , Etnar Mustaparta , Bjarne Brudeli , Olaw Smidsrod , Kjell Varum

IPC分类号： A61K38/17 , A61K31/722 , A61K31/60 , A61K31/192

CPC分类号： A61K31/37 , A61K9/0043 , A61K9/146 , A61K9/19 , A61K9/4866 , A61K9/5036 , A61K31/167 , A61K31/19 , A61K31/22 , A61K31/43 , A61K31/47 , A61K31/60

摘要： The invention provides a pharmaceutical composition comprising a physiologically active agent and a release sustaining or mucoadhesive agent, characterized in that said release sustaining or mucoadhesive agent comprises a chitosan having a FA of from 0.25 to 0.80.

摘要翻译： 本发明提供一种包含生理活性剂和释放维持或粘膜粘附剂的药物组合物，其特征在于所述释放维持或粘膜粘附剂包含具有0.25至0.80的FATAA的壳聚糖。